Advertisement
Advertisement
U.S. Markets close in 4 hrs 45 mins
Advertisement
Advertisement
Advertisement
Advertisement

Awakn Life Sciences Corp. (AWKN.NE)

NEO - NEO Real Time Price. Currency in CAD
Add to watchlist
2.5000+0.0400 (+1.63%)
As of 11:09AM EDT. Market open.
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close2.4600
Open2.5000
Bid2.4900 x N/A
Ask2.5000 x N/A
Day's Range2.5000 - 2.5500
52 Week Range1.5000 - 2.5500
Volume17,844
Avg. Volume18,291
Market CapN/A
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Market Exclusive

    Cannabis Sector Weekly Roundup

    Key Takeaways: Trulieve continued to reopen Harvest stores and add to its Florida footprint, which now includes 102 stores. It also added a dispensary in Pittsburgh, giving it 14 in Pennsylvania. Greenlane Holdings will be buying DaVinci, a vaporizer company, for up to $20 million in cash, stock and earnouts and milestones. Curaleaf Holdings expanded […] The post Cannabis Sector Weekly Roundup appeared first on Market Exclusive.

  • Newsfile

    Awakn Life Sciences to Present at the Benzinga Global Small Cap Conference

    Toronto, Ontario--(Newsfile Corp. - October 22, 2021) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ('Awakn'), a biotechnology company developing and delivering psychedelic therapeutics (medicines and therapies) to treat addiction, announced today that Chief Executive Officer, Anthony Tennyson, will present a corporate overview at the Benzinga Global Small Cap Conference, which is being held virtually on October 27 - 28, 2021.Mr. Tennyson will deliver his presentation on Wedn

  • Newsfile

    Awakn Life Sciences Bristol Clinic Receives Care Quality Commission Approval to Begin Treatments in the UK's First Medical Psychedelic Clinic

    The clinic will begin delivering ketamine-assisted psychotherapy treatments in October Toronto, Ontario--(Newsfile Corp. - October 20, 2021) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ('Awakn'), a biotechnology company developing and delivering psychedelic therapeutics (medicines and therapies) to treat addiction, announced today that Awakn Clinics Bristol has received Care Quality Commission's (CQC) formal approval to begin treatments."This is a very exciting moment for A

Advertisement
Advertisement